McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
692.24
-1.21 (-0.17%)
At close: Sep 17, 2025, 4:00 PM EDT
693.25
+1.01 (0.15%)
Pre-market: Sep 18, 2025, 8:02 AM EDT
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | 345.96B | 327.72B | 313.34B | 299.25B | 283.29B | 278.74B | 271.63B | 260.54B | |||||||||||||
| U.S. Pharmaceutical Growth | 22.12% | 17.57% | 15.36% | 14.86% | 12.94% | 15.84% | 16.77% | 15.42% | |||||||||||||
| International | 14.77B | 14.72B | 14.81B | 14.59B | 14.35B | 14.13B | 13.95B | 14.76B | |||||||||||||
| International Growth | 2.89% | 4.18% | 6.19% | -1.14% | -18.06% | -31.40% | -45.88% | -52.06% | |||||||||||||
| Medical-Surgical Solutions | 11.45B | 11.39B | 11.37B | 11.45B | 11.34B | 11.31B | 11.17B | 11.12B | |||||||||||||
| Medical-Surgical Solutions Growth | 1.00% | 0.65% | 1.84% | 2.99% | 1.88% | 1.83% | -1.15% | -2.38% | |||||||||||||
| Prescription Technology Solutions | 5.41B | 5.22B | 5.06B | 4.89B | 4.77B | 4.77B | 4.77B | 4.69B | |||||||||||||
| Prescription Technology Solutions Growth | 13.49% | 9.37% | 5.99% | 4.35% | 4.40% | 8.71% | 12.92% | 13.35% |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | 3.95B | 4.00B | 3.77B | 3.22B | 2.74B | 2.79B | 2.49B | 3.03B | |||||||||||||
| U.S. Pharmaceutical Growth | 44.09% | 43.65% | 51.30% | 6.20% | -17.89% | -13.10% | -20.54% | 0.17% | |||||||||||||
| Prescription Technology Solutions | 925.00M | 875.00M | 815.00M | 774.00M | 807.00M | 835.00M | 813.00M | 771.00M | |||||||||||||
| Prescription Technology Solutions Growth | 14.62% | 4.79% | 0.25% | 0.39% | 23.58% | 47.53% | 50.83% | 44.92% | |||||||||||||
| Medical-Surgical Solutions | 806.00M | 773.00M | 759.00M | 758.00M | 913.00M | 952.00M | 973.00M | 1.03B | |||||||||||||
| Medical-Surgical Solutions Growth | -11.72% | -18.80% | -21.99% | -26.62% | -16.08% | -14.77% | -16.34% | -9.62% | |||||||||||||
| International | -211.00M | -213.00M | -237.00M | -222.00M | 352.00M | 319.00M | 292.00M | 302.00M | |||||||||||||
| International Growth | - | - | - | - | 76.88% | 134.56% | - | - |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, Distribution, General, and Administrative | 8.70B | 8.51B | 8.72B | 9.20B | 8.79B | 8.66B | 8.43B | 7.83B | |||||||||||||
| Selling, Distribution, General, and Administrative Growth | -0.98% | -1.73% | 3.43% | 17.50% | 14.32% | 11.33% | 1.07% | -17.98% | |||||||||||||
| Claims and Litigation | - | - | - | 255.00M | 256.00M | 143.00M | - | -15.00M | - | -8.00M | 76.00M | 84.00M | 205.00M | - | - | - | - | - | |||
| Claims and Litigation Growth | - | - | - | - | 236.84% | 70.24% | - | - | - | - | -99.07% | -98.98% | - | - | - | - | - | - | |||
| Restructuring, Impairment, and Other | 177.00M | 140.00M | 244.00M | 216.00M | 73.00M | 115.00M | 209.00M | 236.00M | |||||||||||||
| Restructuring, Impairment, and Other Growth | 142.47% | 21.74% | 16.75% | -8.47% | -69.33% | -44.98% | 33.12% | 63.89% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.